It is widely accepted that the immune pathogenesis of multiple sclerosis starts with activation of central nervous system (CNS)-reactive T cells, which are differentiated towards interferon (IFN)-γ-producing T helper (Th)1 and/or interleukin (IL)-17-producing Th17 cells [4]. Here, IL17A is linked to multiple sclerosis.